810223C

Avanti

C12-NBD Glucosyl Ceramide

N-12-(7-nitro-2-1,3-benzoxadiazol-4-yl)aminododecanoyl-D-glucosyl-β1-1′-sphingosine, chloroform

Empirical Formula (Hill Notation):
C42H71N5O11
CAS号:
分子量:
822.04
NACRES:
NA.25
价格与库存信息目前不能提供

assay

>99% (TLC)

packaging

pkg of 1 × 1 mL (810223C-250ug)

mfr. no.

Avanti Polar Lipids, 810223C

concentration

0.25 mg/mL (810223C-250ug)

shipped in

dry ice

storage temp.

−20°C

Application

C12-NBD Glucosyl Ceramide is suitable for liposome preparation.

Biochem/physiol Actions

Glucosyl ceramide (GlcCer) is produced by GlcCer synthase from ceramide in the cytosolic membranes of Golgi. In the luminal Golgi membrane, GlcCer participates in the generation of glycosphingolipids.

Packaging

5 mL Amber Glass Screw Cap Vial (810223C-250ug)

RIDADR

UN 1888 6.1 / PGIII

分析证书
原产地证书 (CofO)
The effects of chemically synthesized saposin C on glucosylceramide-beta-glucosidase
Yoneshige A, et al.
Clinical Biochemistry, 48(16-17), 1177-1180 (2015)
Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide
D?Angelo G, et al.
Nature, 449(7158), 62-62 (2007)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门

社交媒体

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

Merck

科研、开发、生产。

作为生命科学行业的全球领先供应商,我们致力于为科研、生物技术开发和生产,以及制药药物疗法开发和生产提供各类解决方案和服务。

© 2021年版权归德国达姆施塔特默克集团(Merck KGaA)及/或其附属公司所有。版权所有。

未经许可,严禁复制本网站上的任何资料。